311319-92-3

Upstream product

• 27129-86-8 1-bromomethyl-3,5-dimethylbenzene 
• 197229-98-4 5-ethyl-2-methoxy-6-methyl-3-pivaloylaminopyridine 
• 248248-98-8 N-[5-ethyl-2-methoxy-6-methyl-4-(3,5-dimethylbenzoyl)pyridin-3-yl]-2,2-dimethylpropionamide 
• 248248-99-9 acetic acid (3,5-dimethyl-phenyl)-[3-(2,2-dimethyl-propionylamino)-5-ethyl-2-methoxy-6-methyl-pyridin-4-yl]-methyl ester 
• 248248-97-7 4-(3,5-dimethylbenzyl)-5-ethyl-2-methoxy-6-methyl-3-pivaloylaminopyridine 
• 4530-20-5 BOC-glycine 
• 248246-95-9 3-amino-4-(3,5-dimethylbenzyl)-5-ethyl-6-methylpyridin-2(1H)-one 
• 5779-95-3 3,5-dimethylbenzaldehyde 

Relevant academic research and scientific papers

Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors

Several 4-benzyl analogues of 5-ethyl-6-methyl-4-(phenylthio)pyridin-2(1H)-ones were synthesized and evaluated for their anti-HIV-1 activities. Key transformations include metalation at the 4-C-position of 5-ethyl-2-methoxy-6-methyl-3-pivaloylaminopyridin